NKTX CIK: 1787400

Nkarta, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
246
FY22:
361
FY23:
253
FY24:
273
FY25:
283
(positive)
Change from FY21 to FY25
millions USD
FY21:
28.1
FY22:
112
FY23:
126
FY24:
228
FY25:
122
Total assets
Change from FY21 to FY25
millions USD
FY21:
274
FY22:
473
FY23:
379
FY24:
501
FY25:
404

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
12.9
FY22:
22.0
FY23:
23.3
FY24:
18.9
FY25:
22.3
(negative)
Change from FY21 to FY25
millions USD
FY21:
9.99
FY22:
78.7
FY23:
82.3
FY24:
74.3
FY25:
69.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
251
FY22:
372
FY23:
273
FY24:
408
FY25:
312
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
274
FY22:
473
FY23:
379
FY24:
501
FY25:
404

All amounts in millions USD Data source:SEC EDGAR